Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making

European Urology Oncology · Published 2026-07-01 · DOI 10.1016/j.euo.2026.06.012

Free full text

Authors (17)

Constance Thibault, Hélène Blons, Yves Allory, Alia Harba, Mathieu Roumiguié, Thomas Seisen, Gautier Marcq, Anne Sophie Bajeot, Priscilla Leon, Alexandra Masson-Lecomte, Benjamin Pradère, Evanguelos Xylinas, Doriane Prost, Pierre-Etienne Gabriel, Pierre Laurent-Puig, Morgan Rouprêt, Francois Audenet

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Thibault, C., Blons, H., Allory, Y., et al. (2026). Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making. European Urology Oncology. https://doi.org/10.1016/j.euo.2026.06.012

Related articles

• Integrating clinically actionable biomarkers into bladder cancer care — recommendations from the International Bladder Cancer Group · Nature Reviews Urology · 2026 · Cites or is cited by this article
• Oncological Outcomes of Different Managements of the Distal Ureter in Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma · European Urology Oncology · 2026 · Same journal
• Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients · European Urology Oncology · 2026 · Same journal
• When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era · European Urology Oncology · 2026 · Same journal
• Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study · European Urology Oncology · 2026 · Same journal
• Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non–muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study · European Urology Oncology · 2026 · Same journal
• Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study) · European Urology Oncology · 2026 · Same journal
• PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers · European Urology Oncology · 2026 · Same journal
• Study Protocol of OLIGOPELVIS 2–GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer · European Urology Oncology · 2026 · Same journal
• Outcomes of Intermediate Risk Non–muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials · European Urology Oncology · 2026 · Same journal